Mon, March 13, 2017
Fri, March 10, 2017

Terence Flynn Upgraded (BPMC) to Strong Buy on, Mar 13th, 2017

Terence Flynn of Goldman Sachs, Upgraded "Blueprint Medicines Corporation" (BPMC) to Strong Buy on, Mar 13th, 2017.

Terence has made no other calls on BPMC in the last 4 months.



There is 1 other peer that has a rating on BPMC. Out of the 1 peers that are also analyzing BPMC, 0 agree with Terence's Rating of Hold.



This is the rating of the analyst that currently disagrees with Terence


  • Andrew Berens of "Morgan Stanley" Initiated at Buy on, Wednesday, February 15th, 2017